Anne Wojcicki on genetic privacy, data security, her bid for 23andMe Why California wants to stop 23andMe's sale to former ...

Anne Wojcicki’s nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing ...

Anne Wojcicki’s bid to buy 23andMe ... 2023 data breach. But concern what new ownership could mean for 23andMe users’ ...

Anne Wojcicki’s winning bid to reclaim control of 23andMe (MEHCQ) doesn’t necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer ...

A bankruptcy court approved the $305M sale of 23andMe to a nonprofit led by Anne Wojcicki, raising questions about data ...

A bankruptcy court must still approve the sale. The nonprofit TTAM Research Institute — an acronym for 23andMe — outbid Regeneron with a purchase price of $305 million.

Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.

23andMe co-founder and CEO Anne Wokcicki won back control of the genetic-test company after a prolonged bankruptcy fight that at one point was won by Regeneron.

TTAM Research Institute, a non-profit public benefit company also founded by Wojcicki, won the auction with a $305 million bid for the 23andMe assets, which will not come with any company liabilities ...

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.

Anne Wojcicki's winning bid to reclaim control of 23andMe doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics company.